Mi‐Ok Kim - Publications, H-index & Citations

Mi‐Ok Kim

UCSF

47H指数

462论文数

9.4K被引数

收录论文 118

发表时间

KRAS is required for plexiform neurofibroma formation and represents a targetable vulnerability in established tumors KRAS对于丛状神经纤维瘤的形成是必需的，并在已建立的肿瘤中代表一个可靶向的脆弱性

Science Advances

IF12.5

2026-09-02

OAAI

Liang Hu; Niousha Ahmari; Abby Schaeper; Jay Pundavela; Mi-Ok Kim; Eva Dombi; Jianqiang Wu; Julia Brunmair; Özlem Yüce Petronczki; Nancy Ratner

Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM 阿菲卡孟与梗阻性肥厚型心肌病心脏力学改善相关：FOREST-HCM研究的结果

Progress in Cardiovascular Diseases

IF7.6

2026-08-25

PREAI

Mei-Ling Chen; James Hodovan; Ahmad Masri; Victoria Liu; Mi-Ok Kim; Chiara Melloni; Daniel L. Jacoby; Stephen B. Heitner; Theodore P. Abraham

Detailed racial/ethnic disparities in hepatocellular carcinoma risk with an electronic health record-based cohort 基于电子健康记录队列的肝细胞癌风险详细种族/族裔差异

Clinical Gastroenterology and Hepatology

IF12

2026-08-04

PREAI

Mindy C. DeRouen; Caroline A. Thompson; Alison J. Canchola; Alyssa Cortella; Terri Rice; Pushkar Inamdar; Sixiang Nie; Jane Vu; Pragati Kenkare; Janet N. Chu; Anna D. Rubinsky; Yihe G. Daida; Chanda Ho; Su-Ying Liang; Hashem B. El-Serag; Michele M. Tana; Ma Somsouk; Mark Segal; Mi-Ok Kim; Iona Cheng

Valosin-Containing Protein Contributes to Plexiform Neurofibroma Formation and Represents a Novel Therapeutic Target 含Valosin蛋白对丛状神经纤维瘤形成有贡献，并代表一个新型治疗靶点

Cells

IF5.2

2026-05-06

OAAI

Lalitha Gopalan; Youjin Na; Liang Hu; Ashley Hall; Mi-Ok Kim; Eva Dombi; Sara Szabo; Nancy Ratner; Gang Huang; Jianqiang Wu

Patient-derived xenograft models of Fanconi anemia-associated head and neck cancer identify personalized therapeutic strategies 范可尼贫血相关头颈癌的患者来源异种移植模型识别个性化治疗策略

Journal of Clinical Investigation

IF13.6

2026-02-16

PREAI

Grandis, Jennifer R.; Li, Hua; Harrison, Benjamin A.; Webster, Andrew L. H.; Pucilowska, Joanna; Nguyen, Austin; Lee, Jinho; Mills, Gordon B.; Gencel-Augusto, Jovanka; Zeng, Yan; Long, Steven R.; Kim, Mi-Ok; Lee, Rex H.; Kutler, David I.; Scognamiglio, Theresa; Brandwein-Weber, Margaret; Urken, Mark; Khodos, Inna; De Stanchina, Elisa; Lin, Yu-Chien; Donovan, Frank X.; Chandrasekharappa, Settara C.; Jung, Moonjung; Sanders, Mathijs A.; Smogorzewska, Agata; Johnson, Daniel E.

Multi-institutional analysis of incidence and risks for late-onset immune toxicity in breast cancer 多中心分析乳腺癌晚期免疫毒性的发生率和风险

npj Breast Cancer

IF7.6

2025-12-03

OAAI

Saya Jacob; Samantha Fisch; Carolyne Face; Kelly Blum; Madhuri Chengappa; Saliha Chaudhry; Alexis LeVee; Nikita V. Baclig; Andrew Soliman; Laura A. Huppert; Zoe Quandt; Laura Quintal; Dame Idossa; Michelle Melisko; A. Jo Chien; Mi-Ok Kim; Joanne Mortimer; Kelly McCann; Anne Blaes; Hope S. Rugo

Bayesian Random-Effects Meta-Analysis Integrating Individual Participant Data and Aggregate Data

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

IF3

2025-10-02

PREAI

Huang, Yunxiang; Kim, Hang J.; Huang, Chiung-Yu; Kim, Mi-Ok

Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas 日间给予SHP2抑制剂（在免疫细胞数量升高时）可缩小神经纤维瘤

LIFE SCIENCE ALLIANCE

IF2.9

2025-09-24

PREAI

Ahmari, Niousha; Choi, Kwangmin; Wu, Jianqiang; Rizvi, Tilat A.; Jackson, Mark; Kershner, Leah J.; Kim, Mi-Ok; Zhang, Xiyuan; Dombi, Eva; Shern, Jack; Hildeman, David A.; Ratner, Nancy

Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer 靶向STAT3的环状寡核苷酸的安全性与有效性：从小鼠模型到患有口腔癌的宠物猫的1期临床试验

Cancer Cell

IF44.5

2025-08-28

PREAI

Jennifer R. Grandis; Katherine A. Skorupski; Ning Cheng; Zhibin Cui; Hua Li; Liam C. Woerner; Jovanka Gencel-Augusto; Yan Zeng; Jamie V. Shiah; Neil E. Bhola; Malabika Sen; Kelly Blum; Mi-Ok Kim; Daniel York; Robert B. Rebhun; Hong Chang; Natalia F. Murad; Adam B. Olshen; Ellen E. Sparger; Daniel E. Johnson

Comparative study of intra- and inter-observer variability in manual scoring of HER2 immunohistochemical stains on glass slides versus paired digital images with emphasis on the low end of the expression spectrum 玻璃载玻片上HER2免疫组化染色的手动评分中，比较观察者内部和观察者之间的变异性，以及配对数字图像在表达谱低端的比较研究

Human Pathology

IF2.6

2025-06-25

PREAI

Andrew Xiao; Poonam Vohra; Yunn-Yi Chen; Leah Ung; Mi-Ok Kim; Joseph Geradts

Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC)多中心回顾性队列研究：评估抗体药物偶联物（ADCs）曲妥珠单抗德鲁替康（T-DXd）和沙西珠单抗戈维他尼（SG）序贯用于HER2低表达转移性乳腺癌（MBC）患者的疗效

NPJ BREAST CANCER

IF7.6

2025-04-15

OAAI

Huppert, Laura A.; Mahtani, Reshma; Fisch, Samantha; Dempsey, Naomi; Premji, Sarah; Raimonde, Angelina; Jacob, Saya; Quintal, Laura; Melisko, Michelle; Chien, Jo; Sandoval, Ana; Carcas, Lauren; Ahluwalia, Manmeet; Harpalani, Natasha; Hoppenworth, Jenna; Blaes, Anne; Blum, Kelly; Kim, Mi-Ok; Idossa, Dame; Rao, Ruta; Giridhar, Karthik V.; Rugo, Hope S.

A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer

NPJ BREAST CANCER

IF7.6

2025-02-13

OAAI

Mukhtar, Rita A.; Gottipati, Soumya; Yau, Christina; Lopez-Tarruella, Sara; Earl, Helena; Hayward, Larry; Hiller, Louise; Osdoit, Marie; van der Noordaa, Marieke; de Croze, Diane; Hamy, Anne-Sophie; Lae, Marick; Reyal, Fabien; Sonke, Gabe S.; Steenbruggen, Tessa G.; van Seijen, Maartje; Wesseling, Jelle; Martin, Miguel; del Monte-Millan, Maria; Boughey, Judy C.; Goetz, Matthew P.; Hoskin, Tanya; Valero, Vicente; Edge, Stephen B.; Abraham, Jean E.; Bartlett, John M. S.; Caldas, Carlos; Dunn, Janet; Provenzano, Elena; Sammut, Stephen-John; Thomas, Jeremy S.; Graham, Ashley; Hall, Peter; Mackintosh, Lorna; Fan, Fang; Godwin, Andrew K.; Schwensen, Kelsey; Sharma, Priyanka; Demichele, Angela M.; Cole, Kimberly; Pusztai, Lajos; Kim, Mi-Ok; van 't Veer, Laura; Cameron, David; Esserman, Laura J.; Fraser Symmans, W.

Skin Cancer Diagnosis by Lesion, Physician, and Examination Type A Systematic Review and Meta-Analysis 皮肤癌诊断：基于病灶、医师和检查类型的系统评价与Meta分析

JAMA DERMATOLOGY

IF11

2025-02-01

PREAI

Chen, Jennifer Y.; Fernandez, Kristen; Fadadu, Raj P.; Reddy, Rasika; Kim, Mi-Ok; Tan, Josephine; Wei, Maria L.

Real-world Long-term Effectiveness of Mavacamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: a Multicenter Observational Study (MARVEL-HCM)Mavacamten在症状性梗阻性肥厚型心肌病患者中的真实世界长期有效性：一项多中心观察性研究（MARVEL-HCM）

CIRCULATION

IF38.6

2024-11-12

PREAI

Abraham, Theodore; Alsidawi, Said; Martinez, Matthew; Wheeler, Matthew; Roehl, Kaitlin; Patel, Ruchi; Soutar, Marybeth; Herry, Morgane; Wang, Manchen Annie; Kim, Mi-Ok; Schuler, Patricia; Dubey, Anand

Racial and ethnic differences in receipt of guideline-recommended hepatocellular carcinoma surveillance in a high Risk, diverse primary care patient population: A study in two large integrated healthcare systems in California and Hawai'

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2024-09-21

PREAI

Zhang, Enyao Y.; DeRouen, Mindy; Canchola, Alison J.; Cortella, Aly M.; Inamdar, Pushkar; Chu, Janet N.; Nie, Sixiang; Vu, Mai; Somsouk, Ma; Tana, Michele M.; Rubinsky, Anna D.; Cheng, Iona; Kim, Mi-Ok; Segal, Mark; Ho, Chanda; Daida, Yihe G.; Liang, Su-Ying; El-Serag, Hashem B.; Gomez, Scarlett L.; Shariff-Marco, Salma; Thompson, Caroline A.

Exploring liver cancer risk factors by birth cohort: An electronic health record (EHR)-based epidemiologic cohort study

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2024-09-21

PREAI

Chu, Janet N.; Cortella, Aly; Canchola, Alison J.; Inamdar, Pushkar; Nie, Sixiang; Vu, Mai; Somsouk, Ma; Tana, Michele M.; Thompson, Caroline A.; Ho, Chanda; El-Serag, Hashem B.; Kim, Mi-Ok; Segal, Mark; Daida, Yihe G.; Liang, Su-Ying; Gomez, Scarlett L.; Derouen, Mindy C.; Shariff-Marco, Salma

Racial and ethnic differences in breast cancer prognosis and survival in a multiethnic cohort of Asian American breast cancer patients compared with non-Latina White patients at Kaiser Permanente Northern California

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2024-09-21

PREAI

Kwan, Marilyn; D'Addario, Lia; Roh, Janise; Ergas, Isaac; Lee, Catherine; Shariff-Marco, Salma; Cheng, Iona; McGuire, Valerie; Von Behren, Julie; Lin, Katherine; Castillo, Esperanza; Kim, Mi-Ok; John, Esther; Wu, Anna; Woo, Lenora; Kurian, Allison; Omilian, Angela; Ambrosone, Christine; Yao, Song; Gomez, Scarlett; Kushi, Lawrence

Refined race and ethnicity categories for an EHR-based cohort to study disparities in liver cancer risk

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

DeRouen, Mindy C.; Thompson, Caroline A.; Canchola, Alison J.; Cortella, Alyssa; Inamdar, Pushkar; Chu, Janet; Nie, Sixiang; Vu, Mai; Somsouk, Ma; Tana, Michele M.; Rubinsky, Anna D.; Cheng, Iona; Kim, Mi-Ok; Segal, Mark; Ho, Chanda; Daida, Yihe G.; Liang, Su-Ying; El-Serag, Hashem B.; Gomez, Scarlett L.; Shriff-Marco, Salma

C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis

LIFE SCIENCE ALLIANCE

IF2.9

2024-03-08

OAAI

Perrino, Melissa R.; Ahmari, Niousha; Hall, Ashley; Jackson, Mark; Na, Youjin; Pundavela, Jay; Szabo, Sara; Woodruff, Trent M.; Dombi, Eva; Kim, Mi-Ok; Kohl, Jorg; Wu, Jianqiang; Ratner, Nancy

Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer

BREAST CANCER RESEARCH AND TREATMENT

IF3

2024-01-09

OAAI

Umashankar, Saumya; Li, Moming; Blevins, Kaylee; Kim, Mi-Ok; Majure, Melanie; Park, John; Huppert, Laura A.; Melisko, Michelle; Rugo, Hope S.; Esserman, Laura; Chien, A. Jo

研究方向